Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Cooley says it advised Corxel on its planned combination with Amanat Acquisition
Cooley said it advised Corxel on its planned business combination with Amanat Acquisition Corp. The firm said the transaction and concurrent private investment were expected to provide approximately $377 million in gross proceeds before expenses, assuming no redemptions by the acquisition company’s shareholders.
Key points
- Cooley said Corxel US would become a wholly owned subsidiary of the combined company.Cooley
- The firm said the proceeds were expected to fund operations through 2029.Cooley
- Cooley said development plans included a Phase 3 trial of CX11 for obesity.Cooley
- The firm said it previously advised Corxel on its 2026 Series D financing.Cooley